home / stock / phguf / phguf short
Short Information | Pharming Group Nv Ord (OTCMKTS:PHGUF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 36,619 |
Total Actual Volume | 55,781 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 18 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,831 |
Average Short Percentage | 88.21% |
Is there a PHGUF Short Squeeze or Breakout about to happen?
See the PHGUF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-11-2024 | $1.18 | $1.2 | $1.2 | $1.18 | 400 | 200 | 50% |
12-08-2023 | $1.15 | $1.15 | $1.15 | $1.15 | 2,000 | 2,000 | 100% |
09-21-2023 | $1.35 | $1.4 | $1.4 | $1.35 | 400 | 400 | 100% |
07-13-2023 | $1.22 | $1.24 | $1.24 | $1.22 | 14,450 | 1,450 | 10.03% |
07-11-2023 | $1.2 | $1.2 | $1.2 | $1.2 | 600 | 600 | 100% |
06-09-2023 | $0 | $1.2 | $0 | $0 | 10 | 10 | 100% |
06-07-2023 | $1.2 | $1.2 | $1.2 | $1.2 | 1,000 | 1,000 | 100% |
05-15-2023 | $1.17 | $1.17 | $1.17 | $1.17 | 100 | 100 | 100% |
04-21-2023 | $1.09 | $1.09 | $1.09 | $1.09 | 400 | 400 | 100% |
04-13-2023 | $1.16 | $1.16 | $1.16 | $1.16 | 100 | 100 | 100% |
04-05-2023 | $1.18 | $1.18 | $1.18 | $1.18 | 5,060 | 5,060 | 100% |
03-28-2023 | $1.26 | $1.26 | $1.26 | $1.26 | 100 | 100 | 100% |
03-24-2023 | $1.1 | $1.505 | $1.59 | $1.1 | 5,548 | 2,055 | 37.04% |
03-20-2023 | $1.05 | $1.03 | $1.05 | $1.03 | 14,500 | 12,050 | 83.1% |
03-15-2023 | $1.15 | $1.15 | $1.15 | $1.15 | 300 | 300 | 100% |
03-07-2023 | $1.25 | $1.25 | $1.25 | $1.25 | 100 | 100 | 100% |
03-03-2023 | $1.24 | $1.24 | $1.24 | $1.24 | 1,794 | 1,794 | 100% |
03-01-2023 | $1.23 | $1.23 | $1.23 | $1.23 | 2,000 | 2,000 | 100% |
01-30-2023 | $1.4299 | $1.4299 | $1.4299 | $1.4299 | 119 | 100 | 84.03% |
01-24-2023 | $1.3799 | $1.3799 | $1.3799 | $1.3799 | 6,800 | 6,800 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
OTCMKTS Market:
Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming” or “...
This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHAR...
Leiden, The Netherlands, April 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of April: 23rd Annual Needham Virtual Healthc...